510(k) · Radiology

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)

by Ever Fortune.AI, Co., Ltd.

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is an AI-enabled medical device from Ever Fortune.AI, Co., Ltd. that the U.S. FDA cleared through 510(k) K242821 on February 20, 2025. Its lead review panel is Radiology and its primary product code is QAS (Radiological Computer-Assisted Triage And Notification Software).

See also FDA-cleared AI radiology devices in 2025, all FDA AI clearances in 2025, top radiology AI devices.

Key facts

Submission numberK242821
Pathway510(k)
Date of final decision
Company (FDA list)Ever Fortune.AI, Co., Ltd.
Lead review panelRadiology
Primary product codeQAS — Radiological Computer-Assisted Triage And Notification Software
Applicant (openFDA)Ever Fortune.Ai, Co., Ltd.
Applicant locationTaichung City, TW
Device classClass 2
Regulation number21 CFR 892.2080
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) went through this pathway (K242821).

openFDA lists it as a Class 2 device under 21 CFR 892.2080. Class II devices are moderate risk and are subject to general and special controls.

Product code QAS covers 86 devices on the FDA AI list. By decision date, this device is #66 of 86 under that code. Ever Fortune.AI, Co., Ltd. has 10 AI-enabled devices on the list, and the Radiology panel accounts for 1,230 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code QAS)

More from Ever Fortune.AI, Co., Ltd.